Tirzepatide has quickly become one of the most sought-after weight management treatments, and it works a little differently from earlier GLP-1 medications. Instead of targeting one hormone pathway, tirzepatide activates two, which is why it's often described as a 'dual-action' peptide. Here's what that means in practice, and what to expect if you're considering it.
What Is Tirzepatide?
Tirzepatide is a synthetic peptide that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. These are two natural gut hormones involved in appetite regulation, insulin release, and blood sugar control. By engaging both pathways at once, tirzepatide's effects on appetite and metabolism tend to be more pronounced than single-pathway GLP-1 medications.
Peptide Dispensary offers tirzepatide pens in 5mg (20mg/2.4ml), 10mg (40mg/2.4ml), and 15mg (60mg/2.4ml) strengths, with dosing individualised by your prescriber.
How Tirzepatide Works
GIP and GLP-1 work together to enhance insulin secretion, improve insulin sensitivity, and reduce appetite. Research suggests that co-activating both receptors produces a stronger effect on food intake and body weight than activating GLP-1 receptors alone, while also supporting improvements in cholesterol levels, blood pressure, and visceral fat. The result for most people is a stronger sense of fullness, fewer cravings, and steadier energy between meals.
Dosing & Administration
Like semaglutide, tirzepatide is a once-weekly subcutaneous injection delivered via a pre-filled pen. Treatment usually starts at a lower dose and is increased gradually over time to build tolerance and reduce gastrointestinal side effects. Your prescriber will guide your titration schedule based on how you respond.
Benefits of Tirzepatide
• Dual-hormone action for a stronger effect on appetite and satiety
• Meaningful, sustained weight loss when paired with lifestyle changes
• Improved blood sugar control and insulin sensitivity
• Positive effects on cholesterol, blood pressure, and visceral fat in clinical research
• Convenient once-weekly injection
Possible Side Effects
The most commonly reported side effects are gastrointestinal, including nausea and vomiting, particularly during early treatment or dose increases. These tend to be mild to moderate and generally improve over time. Because GIP receptor activation isn't linked to the same GI effects as GLP-1 alone, some people tolerate tirzepatide well even at higher doses, but individual response varies, so close communication with your prescriber matters.
Tirzepatide vs. Semaglutide: How Do You Choose?
Both medications work with your body's natural appetite-regulating hormones, but tirzepatide's dual GIP/GLP-1 action has shown a more pronounced effect on weight and metabolic markers in head-to-head research. That doesn't automatically make it the right choice for everyone, tolerance, health history, budget, and personal response all factor into the decision. The most reliable way to choose is a proper consultation, where your prescriber can weigh these factors against your specific goals rather than relying on generic comparisons.
Getting Started Safely
Before starting tirzepatide, your prescriber will typically review your medical history, discuss your goals, and confirm there are no contraindications. From there, treatment is introduced gradually, with regular follow-ups to track your progress, manage any side effects, and adjust your dose as needed. This structured approach is what separates medically supervised treatment from unsupervised or unregulated use.
Frequently Asked Questions
How is tirzepatide different from semaglutide?
Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors. This dual action is associated with more pronounced effects on appetite and weight in clinical studies, though individual results vary.
What dose of tirzepatide should I start on?
Your prescriber determines your starting dose and titration schedule based on your health history, goals, and tolerance. Devonbosch Pharmacy stocks 5mg, 10mg, and 15mg pens to support individualised dosing.
How often is tirzepatide injected?
Once a week, on the same day each week, via subcutaneous injection.
Is tirzepatide safe long-term?
Tirzepatide should only be used under medical supervision, with regular check-ins to monitor progress and side effects. Your prescriber can advise on the appropriate duration of treatment for your situation.
Book Your Consultation
Ready to find out if tirzepatide is right for you? Start your journey today!